EVRY, France, March 3 /PRNewswire/ -- Genethon, the french laboratory created and funded by the AFM (French Association against Myopathies) using donations from Téléthon, has announced on the 20th of February that it has produced, controlled and released a batch of lentiviral vectors derived from the human immunodeficiency (HIV) virus for a gene therapy trial in humans in a rare immune deficiency. The Etablissement de thérapie génique et cellulaire (ETGC - gene and cell therapy unit) at Généthon thus becomes the first organisation in Europe to have produced this type of vector in accordance with GMP (good manufacturing practice) standards. Part of the safety controls were carried out by GenoSafe(1), a company created by the AFM and Généthon.

SHENYANG, China, March 3 /PRNewswire/ --

- Also Included in Global Services 100 and Top 10 Best Performers in IT Services

The list of 2009 Global Services 100 by the US-based Global Services and neoIT was released recently in New York. Neusoft Corporation (600718.SH), a leading IT solutions services provider as well as the largest offshore software service outsourcing provider in China, was listed among the Global Services 100 for the fifth time and continued ranking No. 1 in the category of Leaders: Emerging Asian Markets for three successive years since 2007. Moreover, Neusoft also made a breakthrough in the categories of Best Performers: IT Services and Leaders: Human Capital Development.

AUSTIN, Texas, March 3 /PRNewswire/ --

- Nine New ARM Cortex-M3-based Microcontrollers Unveiled in Low Power 130nm Technology

LONDON, March 3 /PRNewswire/ -- Applied Industrial Logic and Eonic today announced a partnership aimed at providing UK brokers and insurers with OpenQuote, the world's number one open source insurance solution (based upon number of downloads during the last six months).

OpenQuote was created by Applied Industrial Logic to help reduce both the time-to-market and costs of web-enabling quotations for insurance products and schemes. The software allows insurers, brokers and agents to efficiently release and maintain their products, by configuring risk capture, risk assessment and rating rules.

PARIS, March 3 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces today that its most advanced injectable antibacterial, which combines Novexel's broad spectrum beta lactamase inhibitor, NXL104, with the well established cephalosporin antibiotic, ceftazidime, has entered a second Phase II clinical trial.

CeBIT - HANNOVER, Germany, March 3 /PRNewswire/ --

- deCarta WLNA Fleet Europe Streamlines Development of Fleet and Mobile Resource Management Navigation Solutions

LONDON, March 3 /PRNewswire/ --

CMPMedica, the global healthcare information provider which is a division of United Business Media Limited, has signed an agreement with MAIDIS, the international healthcare software vendor, to provide an integrated medicine management system for two hospitals in the United Arab Emirates (UAE).

LONDON, March 3 /PRNewswire/ --

- Ben Holmes Named Partner

Index Ventures today announced the closing of a euro 350 million early stage fund, Index Ventures V. The fund is dedicated to early stage and seed investments in the technology, biotechnology and clean technology sectors across Europe, the United States and Israel. It is the fifth early stage fund Index has raised in the past ten years and reinforces the firm's commitment to investing in innovative and disruptive companies, from the very earliest stages. The fund was raised almost entirely from the firm's existing base of limited partners.